P2X4 receptors of microglia in neuropathic pain

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12 receptors) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Especially P2X4 receptors (P2X4Rs) make a critical contribution to the pain processing. P2X4Rs of microglia might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial P2X4Rs may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project. Recently, we found that CCL21 regulates the expression of P2X4Rs in different manners, respectively. These new findings also provide novel targets for developing anti-neuropathic pain medicines.

Original languageEnglish
Pages (from-to)699-704
Number of pages6
JournalCNS and Neurological Disorders - Drug Targets
Volume11
Issue number6
DOIs
Publication statusPublished - Nov 19 2012

Fingerprint

Purinergic P2X4 Receptors
Microglia
Neuralgia
Purinergic P2Y12 Receptors
Purinergic P2X7 Receptors
Pain
Peripheral Nerve Injuries
Spinal Cord

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Pharmacology

Cite this

P2X4 receptors of microglia in neuropathic pain. / Inoue, Kazuhide; Makoto, Tsuda.

In: CNS and Neurological Disorders - Drug Targets, Vol. 11, No. 6, 19.11.2012, p. 699-704.

Research output: Contribution to journalArticle

@article{fe4b8712e586496f8f1ec10759970c38,
title = "P2X4 receptors of microglia in neuropathic pain",
abstract = "We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12 receptors) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Especially P2X4 receptors (P2X4Rs) make a critical contribution to the pain processing. P2X4Rs of microglia might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial P2X4Rs may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project. Recently, we found that CCL21 regulates the expression of P2X4Rs in different manners, respectively. These new findings also provide novel targets for developing anti-neuropathic pain medicines.",
author = "Kazuhide Inoue and Tsuda Makoto",
year = "2012",
month = "11",
day = "19",
doi = "10.2174/187152712803581065",
language = "English",
volume = "11",
pages = "699--704",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - P2X4 receptors of microglia in neuropathic pain

AU - Inoue, Kazuhide

AU - Makoto, Tsuda

PY - 2012/11/19

Y1 - 2012/11/19

N2 - We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12 receptors) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Especially P2X4 receptors (P2X4Rs) make a critical contribution to the pain processing. P2X4Rs of microglia might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial P2X4Rs may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project. Recently, we found that CCL21 regulates the expression of P2X4Rs in different manners, respectively. These new findings also provide novel targets for developing anti-neuropathic pain medicines.

AB - We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12 receptors) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Especially P2X4 receptors (P2X4Rs) make a critical contribution to the pain processing. P2X4Rs of microglia might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial P2X4Rs may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project. Recently, we found that CCL21 regulates the expression of P2X4Rs in different manners, respectively. These new findings also provide novel targets for developing anti-neuropathic pain medicines.

UR - http://www.scopus.com/inward/record.url?scp=84869061119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869061119&partnerID=8YFLogxK

U2 - 10.2174/187152712803581065

DO - 10.2174/187152712803581065

M3 - Article

C2 - 22963435

AN - SCOPUS:84869061119

VL - 11

SP - 699

EP - 704

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 6

ER -